Pfizer Inc.:企業の戦略・SWOT・財務情報

MarketLineが発行した調査報告書(DATA904C4423)
◆英語タイトル:Pfizer Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4423
◆発行会社(リサーチ会社):MarketLine
◆発行日:2018年8月
◆ページ数:71
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketLine社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Pfizer Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Pfizer Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Pfizer Inc. (Pfizer or ‘the company’) is a research based global biopharmaceutical company. The company provides medicines, vaccines, consumer healthcare products and therapies to treat various conditions including inflammation, cancer, besides vaccines, infection and immune disorders and rare diseases. It also provides active pharmaceutical ingredients (APIs), biosimilars, sterile injectable pharmaceuticals and contract manufacturing services. The company sells consumer healthcare products through pharmacies, distributors, retail chains and convenience stores. It also sells prescription medicines through wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. The company offers its products in the US and international market. Pfizer is headquartered in New York, the US.

Scope

- Detailed information on Pfizer Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Pfizer Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Pfizer Inc. including a breakdown and examination of key business segments
- Intelligence on Pfizer Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Pfizer Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Pfizer Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Pfizer Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Pfizer Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Pfizer Inc.: Company Overview 9
Pfizer Inc.: Overview and Key Facts 9
Pfizer Inc.: Overview 9
Pfizer Inc.: Key Facts 9
Pfizer Inc.: Key Employees 11
Pfizer Inc.: Key Employee Biographies 13
Pfizer Inc.: Major Products and Services 16
Pfizer Inc.: Company History 18
Pfizer Inc.: Management Statement 35
Pfizer Inc.: Locations and Subsidiaries 37
Pfizer Inc.: Key Competitors 38
Pfizer Inc.: Company Analysis 39
Pfizer Inc.: Business Description 39
Pfizer Inc.: SWOT Analysis 41
Pfizer Inc.: SWOT Overview 41
Pfizer Inc.: Strengths 41
Pfizer Inc.: Weaknesses 42
Pfizer Inc.: Opportunities 42
Pfizer Inc.: Threats 43
Pfizer Inc.: Corporate Financial Deals Activity 45
Pfizer Inc.: Financial Deals Overview 45
Pfizer Inc.: Targets and Partners 47
Pfizer Inc.: Top Deals 2014 – 2018YTD* 52
Pfizer Inc.: Advisors 53
Pfizer Inc.: Top Legal Advisors 53
Pfizer Inc.: Top Financial Advisors 53
Pfizer Inc.: Mergers and Acquisitions 55
Pfizer Inc.: Corporate Venturing 56
Pfizer Inc.: Capital Raising 57
Pfizer Inc.: Partnership 58
Pfizer Inc.: Divestments 59
Pfizer Inc.: Recent Developments 60
Pfizer Inc.: News and Events Summary 60
Pfizer Inc.: Business Expansion 63
Pfizer Inc.: Corporate Social Responsibility 64
Pfizer Inc.: Financial Deals 65
Pfizer Inc.: Financial Performance 66
Pfizer Inc.: Regulatory and Legal Events 66
Pfizer Inc.: Strategy and Operations 67
Appendix 69
Contact Us 69
Methodology 69
About MarketLine 70

List of Tables
Table 1: Pfizer Inc.: Key Facts
Table 2: Pfizer Inc.: Key Employees
Table 3: Pfizer Inc.: Locations and Subsidiaries
Table 4: Pfizer Inc.: Key Competitors
Table 5: Pfizer Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Pfizer Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Pfizer Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Pfizer Inc.: Targets and Partners
Table 9: Pfizer Inc.: Top Deals 2014 - 2018YTD*
Table 10: Pfizer Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Pfizer Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Pfizer Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Pfizer Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Pfizer Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Pfizer Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Pfizer Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 17: Pfizer Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 18: Pfizer Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 19: Pfizer Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 20: Pfizer Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 21: Pfizer Inc.: Divestments by Geography (2014 - YTD*2018)
Table 22: Pfizer Inc.: News and Events Summary
Table 23: Pfizer Inc.: Business Expansion
Table 24: Pfizer Inc.: Corporate Social Responsibility
Table 25: Pfizer Inc.: Financial Deals
Table 26: Pfizer Inc.: Financial Performance
Table 27: Pfizer Inc.: Regulatory and Legal Events
Table 28: Pfizer Inc.: Strategy and Operations

List of Figures
Figure 1: Pfizer Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Pfizer Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Pfizer Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Pfizer Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Pfizer Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Pfizer Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: Pfizer Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 8: Pfizer Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 9: Pfizer Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 10: Pfizer Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 11: Pfizer Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 12: Pfizer Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 13: Pfizer Inc.: Divestments by Geography (2014 - YTD*2018)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Pfizer Inc.:企業の戦略・SWOT・財務情報(Pfizer Inc. - Strategy, SWOT and Corporate Finance Report)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆